Meeting program
October 2, 2021
10:00 - 10:10 EET Opening remarks
10:10 - 11:40 EET Session 1: Multiple myeloma - Diagnosis & staging
Chairs: M Guenova (Bulgaria) & A Ivanaj (Albania)
- State-of-the-Art
E Terpos (Greece) - Prognostic significance of double and triple hit myeloma
M Mitrovic (Serbia) - Berger's disease or MGRS (or both?)
J Batinic (Croatia) - Multiple myeloma, diagnosis and approaches to treatment through the case report
I Miketić (Montenegro) - Discussion
All speakers
11:40 - 12:25 EET Break
12:25 - 13:55 EET Session 2: Multiple myeloma - Frontline therapy
Chairs: S Basic Kinda (Croatia) & H Bumbea (Romania)
- State-of-the-Art
M Beksaç (Türkiye) - Treatment of an elderly transplant ineligible patient with newly diagnosed myeloma
O Gokmen Sevindik (Türkiye) - Treatment approach for young high risk myeloma patients - Implementing the new ESMO guidelines
S Badelita (Romania) - Frontline treatment of patients with multiple myeloma in UMC Ljubljana over the 5-year period - Our experience
N Kavčič (Slovenia) - Discussion
All speakers
13:55 - 14:10 EET Break
14:10 - 15:40 EET Session 3: Multiple myeloma in the Relapsed/Refractory Patient
Chairs: J Bila (Serbia) & S Zver (Slovenia)
- State-of-the-Art
P Sonneveld (The Netherlands) - Impact of new ESMO guidelines on the treatment of RRMM patients in Bulgaria
V Goranova-Marinova (Bulgaria) - A case of Multiple Myeloma patient assiciated with testicular Non Hodgkin Lymphoma
A Cili (Albania) - Management of a patient presented with extramedullary relapse after ASCT followed by lenilidomide maintenance
E Katodritou (Greece) - Discussion
All speakers
15:40 - 16:00 EET Closing remarks - Future in medicine through scientific collaboration
Back